JOINN (06127.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec1

Multiple Executives of ZhaoYan New Drug Completed their Stock Sale Plans

10:14

Nov27

Director Sun Yunxia of Zhaoyan New Drug Reduces 100,000 Shares

12:03

Nov14

Directors of Zhaoyan New Drug Reduced Shares

12:03

Nov13

Huaxi Securities Maintains '增持' Rating for Zhaoyan Pharmaceutical, Predicts Future Demand Improvement

06:44

Nov4

Executives of Syneos Health China Cut Shares Held

12:04

Oct30

JOINN released FY2025 Q3 earnings on October 30 During-Market (BJT), actual revenue HKD 345.86 M (forecast HKD 567.76 M), actual EPS HKD 0.0318 (forecast HKD 0.1434)

08:00

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 345.86 M, Net Income 21.62 M, EPS 0.0318

Aug29

Distribution Plan(CST)

Cash dividend 0.0327 HKD

Aug26

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 417.27 M, Net Income 21.69 M, EPS 0.0309

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change